NIAID Home NIAID Searchable Chemical Database Division of Aids Default NIAID Searchable Chemical Database Classes of Drugs Cellular Target Index of Drugs FDA Approved Drugs Viral Targets Viral Life Cycle Introduction Database for Anti-HIV Compounds - Clickable Menu Bar

NIAID HIV/OI Searchable Chemical Database

NIAID/DAIDS Searchable Chemical Database



Protein Glycosylation

Certain viral proteins undergo glycosylation, which has been pursued as a target for possible intervention (1-2). Castanospermine, a naturally occurring alkaloid and inhibitor of glucosidase-I served as a lead compound for the development of analogs. N-Butyl deoxynojirimycin(butyl-DNJ) and 6-butyl-castanospermine represent analogs with more potent activity against HIV (3).



References

  1. JOHNSON, V.A.; WALKER, B.D.; BARLOW, M.A.; PARADIS, T.J.; CHOU, T.C.; HIRSCH, M.S., SYNERGISTIC INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 REPLICATION IN VITRO BY CASTANOSPERMINE AND 3'-AZIDO-3'-DEOXYTHYMIDINE. ANTIMICROB AGENTS CHEMOTHER 33:53-57 (1989).
  2. RUPRECHT, R.M.; MULLANEY, S.; ANDERSEN, J.; BRONSON, R., IN VIVO ANALYSIS OF CASTANOSPERMINE, A CANDIDATE ANTIRETROVIRAL AGENT. J AIDS 2:149 (1989).
  3. SUNKARA, P.S., TAYLOR, D., KANG, M., BOWLIN, T., LIU, P., TYMS, A., SJOERDSMA, A. ANTI-HIV ACTIVITY OF CASTANOSPERMINE ANALOGS. LANCET, 1989;1:1206 (1989).





Home | 

Privacy Statement | 

Help

comments: chemweb@niaid.nih.gov